BRCA1 (5 mutations) and BRCA2
Material: Blood
Price of the study: 420 PLN
Waiting time: result after 25 working days
Booking:
Price of the study: 420 PLN
Waiting time: result after 25 working days
Booking:
- We perform the test without prior reservation only at selected intake points/hours - NOTE! Check the hours of the tests
Preparation for the study
General
- The test material is blood.
- The patient does not need to be fasting.About 30 minutes before the test, it is advisable to drink a glass of water or bitter(unsweetened) tea.
Important
Samples brought from outside are not accepted for testing.
Description
The test detects mutations in BRCA1 genes that predispose to breast or ovarian cancer; the test targets women with a family history of breast or ovarian cancer.
Detection of mutations (>1% of women) is an indication for more frequent screening and elimination of other risk factors (e.g., smoking, stress, hormone therapy.)
According to recent reports, BRCA gene mutation can also cause other cancers including prostate and pancreatic.
The test detects mutations in the BRCA 2 gene that predispose to breast or ovarian cancer; the test targets women with a family history of breast or ovarian cancer.
It is estimated that if you carry a BRCA1 gene mutation, you are up to 70% likely to develop breast cancer, and up to 40% likely to develop ovarian cancer. This means a 10 times greater likelihood of breast cancer and a 20 times greater risk of ovarian cancer compared to the "average" woman. The risk associated with the BRCA2 gene mutation is lower, at about 56% for breast cancer and 27% for ovarian cancer.
Detection of the mutation (>1% of women) is an indication for more frequent checks and elimination of other risk factors (e.g. smoking, stress, hormone therapy).
Detection of mutations (>1% of women) is an indication for more frequent screening and elimination of other risk factors (e.g., smoking, stress, hormone therapy.)
According to recent reports, BRCA gene mutation can also cause other cancers including prostate and pancreatic.
The test detects mutations in the BRCA 2 gene that predispose to breast or ovarian cancer; the test targets women with a family history of breast or ovarian cancer.
It is estimated that if you carry a BRCA1 gene mutation, you are up to 70% likely to develop breast cancer, and up to 40% likely to develop ovarian cancer. This means a 10 times greater likelihood of breast cancer and a 20 times greater risk of ovarian cancer compared to the "average" woman. The risk associated with the BRCA2 gene mutation is lower, at about 56% for breast cancer and 27% for ovarian cancer.
Detection of the mutation (>1% of women) is an indication for more frequent checks and elimination of other risk factors (e.g. smoking, stress, hormone therapy).
Development and preparation of material (applies to contractors only)
1034
